Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Plasmodium falciparum | serine/threonine protein kinase, putative | 0.0056 | 0.0695 | 0.5 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0056 | 0.0695 | 0.1447 |
Trichomonas vaginalis | AGC family protein kinase | 0.0056 | 0.0695 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.0507 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Leishmania major | hypothetical protein, conserved | 0.0184 | 0.334 | 1 |
Loa Loa (eye worm) | AUR protein kinase | 0.0056 | 0.0695 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0056 | 0.0695 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Schistosoma mansoni | protein kinase | 0.0056 | 0.0695 | 1 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0056 | 0.0695 | 1 |
Echinococcus granulosus | serine:threonine protein kinase 12 B | 0.0056 | 0.0695 | 0.0436 |
Echinococcus granulosus | aurora kinase A | 0.0056 | 0.0695 | 0.0436 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Echinococcus multilocularis | aurora kinase A | 0.0056 | 0.0695 | 0.0436 |
Toxoplasma gondii | aurora kinase | 0.0056 | 0.0695 | 1 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0056 | 0.0695 | 1 |
Brugia malayi | serine/threonine kinase 12 | 0.0056 | 0.0695 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Giardia lamblia | Aurora kinase | 0.0056 | 0.0695 | 1 |
Loa Loa (eye worm) | AUR protein kinase | 0.0056 | 0.0695 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0035 | 0.0271 | 0.3897 |
Trypanosoma brucei | aurora B kinase | 0.0056 | 0.0695 | 1 |
Entamoeba histolytica | protein kinase , putative | 0.0056 | 0.0695 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0035 | 0.0271 | 0.3897 |
Entamoeba histolytica | protein kinase, putative | 0.0056 | 0.0695 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0056 | 0.0695 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Loa Loa (eye worm) | AUR protein kinase | 0.0056 | 0.0695 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0035 | 0.0271 | 0.3897 |
Leishmania major | protein kinase, putative | 0.0056 | 0.0695 | 0.1381 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0056 | 0.0695 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0056 | 0.0695 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0056 | 0.0695 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0177 | 0.32 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase 12 B | 0.0056 | 0.0695 | 0.0436 |
Trichomonas vaginalis | AGC family protein kinase | 0.0056 | 0.0695 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Plasmodium vivax | serine/threonine protein kinase 6, putative | 0.0056 | 0.0695 | 0.5 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0056 | 0.0695 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Trichomonas vaginalis | AGC family protein kinase | 0.0056 | 0.0695 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.3897 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0056 | 0.0695 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 15 % | The concentration to inhibit colony formation of PC3 human tumour cell lines | ChEMBL. | 9341910 |
Inhibition (functional) | = 15 % | The concentration to inhibit colony formation of PC3 human tumour cell lines | ChEMBL. | 9341910 |
Inhibition (functional) | = 21 % | The concentration to inhibit colony formation of Ishikawa human tumour cell lines | ChEMBL. | 9341910 |
Inhibition (functional) | = 21 % | The concentration to inhibit colony formation of Ishikawa human tumour cell lines | ChEMBL. | 9341910 |
Inhibition (functional) | = 35 % | The concentration to inhibit colony formation of MDA-MB-231 human tumour cell lines | ChEMBL. | 9341910 |
Inhibition (functional) | = 35 % | The concentration to inhibit colony formation of MDA-MB-231 human tumour cell lines | ChEMBL. | 9341910 |
Inhibition (functional) | = 40 % | The concentration to inhibit colony formation of MCF-7 human tumour cell lines | ChEMBL. | 9341910 |
Inhibition (functional) | = 40 % | The concentration to inhibit colony formation of MCF-7 human tumour cell lines | ChEMBL. | 9341910 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.